These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37827184)

  • 1. Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother-neonate cohort study.
    Li M; Wang W; Chen J; Zhan Z; Xu M; Liu N; Ren L; You L; Zheng W; Shi H; Zhao Z; Huang C; Chen X; Zheng N; Lu W; Zhou X; Zhou J; Liao Q; Yang J; Jit M; Salje H; Yu H
    Lancet Microbe; 2023 Nov; 4(11):e893-e902. PubMed ID: 37827184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother-neonate cohort study.
    Wei X; Yang J; Gao L; Wang L; Liao Q; Qiu Q; Luo K; Yu S; Zhou Y; Liu F; Chen Q; Zhang J; Dai B; Yang H; Zhou J; Xing W; Chen X; He M; Ren L; Guo J; Luo L; Wu P; Chen Z; van Doorn HR; Cauchemez S; Cowling BJ; Yu H
    Lancet Infect Dis; 2021 Mar; 21(3):418-426. PubMed ID: 33031750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
    Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
    Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.
    Helmig RB; Maimburg RD; Erikstrup C; Nielsen HS; Petersen OB; Nielsen LP; Hvidman L; Veirum JE; Henriksen TB; Storgaard M
    Acta Obstet Gynecol Scand; 2015 Aug; 94(8):833-9. PubMed ID: 25958884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023.
    Fossum E; Rohringer A; Aune T; Rydland KM; Bragstad K; Hungnes O
    Virol J; 2024 Mar; 21(1):57. PubMed ID: 38448981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
    Hoschler K; Maharjan S; Whitaker H; Southern J; Okai B; Baldevarona J; Turner PJ; Andrews NJ; Miller E; Zambon M
    Vaccine; 2020 Mar; 38(12):2660-2670. PubMed ID: 32070679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of timing of maternal influenza immunization on infant antibody levels at birth.
    Zhong Z; Haltalli M; Holder B; Rice T; Donaldson B; O'Driscoll M; Le-Doare K; Kampmann B; Tregoning JS
    Clin Exp Immunol; 2019 Feb; 195(2):139-152. PubMed ID: 30422307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
    Liu W; Lien YH; Lee PI; Chan TC; Wang LC; Yang CR; Ho MS; Chen JR; Ku CC; King CC
    Vaccine; 2022 May; 40(24):3402-3411. PubMed ID: 35525727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-pandemic seroprevalence of 2009 pandemic influenza A (H1N1) virus in Shandong Province, China.
    Liu T; Li Z; Song S; Zhang S; Wang Y; Lin Y; Wang S; Wang X; Xu A; Bi Z
    Jpn J Infect Dis; 2012; 65(5):410-4. PubMed ID: 22996214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population.
    Petrie JG; Martin ET; Truscon R; Johnson E; Cheng CK; McSpadden EJ; Malosh RE; Lauring AS; Lamerato LE; Eichelberger MC; Ferdinands JM; Monto AS
    Vaccine; 2019 Feb; 37(10):1284-1292. PubMed ID: 30738647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transfer of maternal antibodies and dynamics of maternal and natural infection-induced antibodies against coxsackievirus A16 in Chinese children 0-13 years of age: a longitudinal cohort study.
    Zhou J; Zhou Y; Luo K; Liao Q; Zheng W; Gong H; Shi H; Zhao S; Wang K; Qiu Q; Dai B; Ren L; Wang L; Gao L; Xu M; Liu N; Lu W; Zheng N; Chen X; Chen Z; Yang J; Cauchemez S; Yu H
    BMC Med; 2022 Nov; 20(1):436. PubMed ID: 36352415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study.
    Laake I; Tunheim G; Robertson AH; Hungnes O; Waalen K; Håberg SE; Mjaaland S; Trogstad L
    BMC Infect Dis; 2018 Oct; 18(1):525. PubMed ID: 30348103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    Petrie JG; Parkhouse K; Ohmit SE; Malosh RE; Monto AS; Hensley SE
    J Infect Dis; 2016 Dec; 214(12):1947-1951. PubMed ID: 27923954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel.
    Weil M; Shohat T; Bromberg M; Bassal R; Dichtiar R; Mandelboim M; Sofer D; Cohen D; Mendelson E
    Influenza Other Respir Viruses; 2013 Sep; 7(5):838-46. PubMed ID: 23280061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation.
    Delabre RM; Salez N; Lapidus N; Lemaitre M; Leruez-Ville M; de Lamballerie X; Carrat F
    Epidemiol Infect; 2017 Jan; 145(1):141-147. PubMed ID: 27682472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.